Kentucky Appeals Court Backs Infuse Off-Label Preemption, But Not For Hospital
FRANKFORT, Ky. — A Kentucky Court of Appeals panel on Jan. 13 affirmed that a patient’s product liability claim over the off-label use of Infuse bone graft is preempted by federal...To view the full article, register now.
Already a subscriber? Click here to view full article